Suchergebnisse - "Cheng, Jun"

PubPharm (40)

1

Hydronidone for the Treatment of Liver Fibrosis Related to Chronic Hepatitis B : A Phase 2 Randomized Controlled Trial

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Cai, X. | Liu, X. | Xie, W. | +12

2

Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B

enthalten in: Journal of medical virology | 2023

von Tang, Y. | Fan, R. | Lan, Z. | +19

CommentIn: J Med Virol. 2023 Mar;95(3):e28654. - PMID 36897035

3

TNF-α inhibitor tanfanercept (HBM9036) improves signs and symptoms of dry eye in a phase 2 trial in the controlled adverse environment in China

enthalten in: International ophthalmology | 2022

von Dong, Y. | Wang, S. | Cong, L. | +13

4

Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses : a phase III clinical trial

enthalten in: BMC gastroenterology | 2020

von Tang, J. | Wang, Y. | Han, T. | +17

5

Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen : Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B

enthalten in: The Journal of infectious diseases | 2020

von Fan, R. | Peng, J. | Xie, Q. | +25

6

Comparison of the clinical outcomes of percutaneous vertebroplasty vs. kyphoplasty for the treatment of osteoporotic Kümmell's disease:a prospective cohort study

enthalten in: BMC musculoskeletal disorders | 2020

von Chang, J. | Bei, M. | Shu, D. | +3

7

Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Fan, R. | Zhou, B. | Xu, M. | +27

CommentIn: Clin Gastroenterol Hepatol. 2020 Mar;18(3):551-552. - PMID 31473358

8

A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B : First-stage results at week 48

enthalten in: Medicine | 2019

von Liang, R. | Xu, J. | Si, C. | +18

9

Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B : 5-year results

enthalten in: Hepatology international | 2019

von Liang, X. | Gao, Z. | Xie, Q. | +23

10

Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis : a prospective multicenter randomized open-label study

enthalten in: Expert opinion on biological therapy | 2018

von Wu, X. | Shi, Y. | Zhou, J. | +22